Prosecution Insights
Last updated: April 19, 2026

Auspex Pharmaceuticals, Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18402393 Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 LIU, TRACY 1614 Non-Final OA Jan 02, 2024
18246582 GASTRO RETENTIVE DOSAGE FORMS COMPRISING DEUTETRABENAZINE MERCIER, MELISSA S 1615 Final Rejection Mar 24, 2023
18245565 MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE MACH, ANDRE 1615 Non-Final OA Mar 16, 2023

Managing Auspex Pharmaceuticals, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month